Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cysteinyl leukotriene receptor 2 | Starlite/ChEMBL | References |
Homo sapiens | cysteinyl leukotriene receptor 1 | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | choline/Carnitine O-acyltransferase | 0.0051 | 0.2121 | 0.2121 |
Leishmania major | N-myristoyl transferase, putative | 0.019 | 0.9494 | 1 |
Leishmania major | choline/Carnitine o-acyltransferase-like protein | 0.0164 | 0.8106 | 0.8117 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.019 | 0.9494 | 1 |
Brugia malayi | N-myristoyltransferase 2 | 0.019 | 0.9494 | 0.9494 |
Echinococcus granulosus | CREB binding protein | 0.0018 | 0.0328 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.2069 | 0.2069 |
Brugia malayi | TAZ zinc finger family protein | 0.0107 | 0.5092 | 0.5092 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0164 | 0.8106 | 0.8106 |
Loa Loa (eye worm) | carnitine O-palmitoyltransferase I isoform | 0.0051 | 0.2121 | 0.2121 |
Schistosoma mansoni | N-myristoyltransferase | 0.019 | 0.9494 | 0.9494 |
Echinococcus multilocularis | choline O acetyltransferase | 0.02 | 1 | 1 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0051 | 0.2121 | 0.2121 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.019 | 0.9494 | 0.5 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0164 | 0.8106 | 0.8117 |
Echinococcus granulosus | carnitine O palmitoyltransferase 1 liver | 0.0164 | 0.8106 | 0.8106 |
Trypanosoma cruzi | choline/carnitine O-acyltransferase, putative | 0.0164 | 0.8106 | 0.8117 |
Loa Loa (eye worm) | choline O-acetyltransferase | 0.02 | 1 | 1 |
Echinococcus granulosus | choline O acetyltransferase | 0.02 | 1 | 1 |
Giardia lamblia | CDC72 | 0.019 | 0.9494 | 0.5 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.019 | 0.9494 | 0.5 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.019 | 0.9494 | 1 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 2 | 0.0051 | 0.2121 | 0.2121 |
Schistosoma mansoni | choline o-acyltransferase | 0.02 | 1 | 1 |
Echinococcus granulosus | CREB binding protein | 0.0018 | 0.0328 | 0.0328 |
Schistosoma mansoni | CREB-binding protein 1 (SmCBP1) | 0.0107 | 0.5092 | 0.5092 |
Trypanosoma brucei | N-myristoyltransferase | 0.019 | 0.9494 | 1 |
Echinococcus granulosus | carnitine O palmitoyltransferase 2 | 0.0051 | 0.2121 | 0.2121 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.019 | 0.9494 | 0.9494 |
Onchocerca volvulus | 0.0051 | 0.2121 | 0.5 | |
Echinococcus multilocularis | CREB binding protein | 0.0018 | 0.0328 | 0.0328 |
Onchocerca volvulus | 0.0051 | 0.2121 | 0.5 | |
Echinococcus multilocularis | CREB binding protein | 0.0074 | 0.3301 | 0.3301 |
Schistosoma mansoni | choline o-acyltransferase | 0.0051 | 0.2121 | 0.2121 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.019 | 0.9494 | 0.9494 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0125 | 0.603 | 0.6351 |
Onchocerca volvulus | 0.0051 | 0.2121 | 0.5 | |
Onchocerca volvulus | 0.0051 | 0.2121 | 0.5 | |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.019 | 0.9494 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.8106 | 0.8106 |
Echinococcus multilocularis | CREB binding protein | 0.0018 | 0.0328 | 0.0328 |
Loa Loa (eye worm) | CBP-B | 0.0075 | 0.3351 | 0.3351 |
Echinococcus granulosus | CREB binding protein | 0.0066 | 0.2908 | 0.2908 |
Brugia malayi | Choline O-acetyltransferase | 0.02 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.02 | 1 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0011 | 0 | 0.5 |
Brugia malayi | Choline/Carnitine o-acyltransferase family protein | 0.0051 | 0.2121 | 0.2121 |
Echinococcus granulosus | CREB binding protein | 0.0107 | 0.5092 | 0.5092 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0011 | 0 | 0.5 |
Echinococcus multilocularis | carnitine O palmitoyltransferase 1, liver | 0.0164 | 0.8106 | 0.8106 |
Echinococcus multilocularis | CREB binding protein | 0.0018 | 0.0328 | 0.0328 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.019 | 0.9494 | 0.9494 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.019 | 0.9494 | 1 |
Schistosoma mansoni | CREB-binding protein 2 | 0.0107 | 0.5092 | 0.5092 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.019 | 0.9494 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1 % conc | Inhibition of leukotriene D4 induced bronchoconstriction in anesthetized guinea pigs after aerosol administration as 1% solution | ChEMBL. | 2547071 |
IC50 (binding) | = 5 uM | Inhibitory activity to block binding of [3H]-leukotriene D4 to LTD4 receptor sites in homogenized guinea pig lung | ChEMBL. | 2547071 |
IC50 (binding) | = 5 uM | Inhibitory activity to block binding of [3H]-leukotriene D4 to LTD4 receptor sites in homogenized guinea pig lung | ChEMBL. | 2547071 |
Inhibition (functional) | = 20 % | Inhibition of leukotriene D4 induced bronchoconstriction in anesthetized guinea pigs after intravenous administration at a dose of 10 mg/kg | ChEMBL. | 2547071 |
Inhibition (functional) | = 46 % | Inhibition of leukotriene D4 induced bronchoconstriction in anesthetized guinea pigs after aerosol administration as 1% solution | ChEMBL. | 2547071 |
Inhibition (binding) | = 65 % | Inhibitory activity to block binding of [3H]-leukotriene D4 to LTD4 receptor sites in homogenized guinea pig lung at 10 uM | ChEMBL. | 2547071 |
Inhibition (binding) | = 65 % | Inhibitory activity to block binding of [3H]-leukotriene D4 to LTD4 receptor sites in homogenized guinea pig lung at 10 uM | ChEMBL. | 2547071 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.